Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 2
1987 2
1988 2
1989 1
1991 3
1992 1
1993 3
1994 1
1995 2
1997 2
1999 3
2000 1
2001 5
2002 5
2003 2
2004 4
2005 4
2006 11
2007 11
2008 9
2009 11
2010 29
2011 21
2012 21
2013 50
2014 43
2015 49
2016 62
2017 62
2018 49
2019 64
2020 76
2021 114
2022 98
2023 98
2024 111
2025 134
2026 89

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,076 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Woodell-May, 5BAuthor
Page 1
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States.
Lin PJ, Riley AG, Synnott PG, Frangiosa TL, Roniger A, Neumann PJ, Cohen JT. Lin PJ, et al. J Alzheimers Dis. 2025 Aug;106(3):943-953. doi: 10.1177/13872877251350381. Epub 2025 Jun 19. J Alzheimers Dis. 2025. PMID: 40534407
BackgroundThe introduction of new Alzheimer's disease (AD) treatments necessitates updated health utilities for economic evaluations.ObjectiveMeasure health utilities of US adults with mild cognitive impairment (MCI) and AD and their caregivers.MethodsWe conducted a web-based sur …
BackgroundThe introduction of new Alzheimer's disease (AD) treatments necessitates updated health utilities for economic evaluations.Objecti …
EQ-5D: a plea for accurate nomenclature.
Brooks R, Boye KS, Slaap B. Brooks R, et al. J Patient Rep Outcomes. 2020 Jul 3;4(1):52. doi: 10.1186/s41687-020-00222-9. J Patient Rep Outcomes. 2020. PMID: 32620995 Free PMC article.
In order to standardise nomenclature, the EuroQol Group agreed in 2001 on a terminology glossary containing 12 items; this was recently revised and augmented to include 22 items and can be found on the Group's website ( www.euroqol.org ). Since 2009, EQ-5D has been …
In order to standardise nomenclature, the EuroQol Group agreed in 2001 on a terminology glossary containing 12 items; this was recently revi …
Randomized controlled trial of supervised physiotherapy versus a home exercise program after hydrodilatation for the management of primary frozen shoulder.
Robinson PM, Norris J, Roberts CP. Robinson PM, et al. J Shoulder Elbow Surg. 2017 May;26(5):757-765. doi: 10.1016/j.jse.2017.01.012. Epub 2017 Mar 18. J Shoulder Elbow Surg. 2017. PMID: 28318848 Clinical Trial.
Other measures were range of movement, visual analog scale pain score, and EQ-5D index. RESULTS: There was no significant difference between the treatment groups at any time point as measured by the OSS or EQ-5D index. ...In group 2, the OSS improved significantly f …
Other measures were range of movement, visual analog scale pain score, and EQ-5D index. RESULTS: There was no significant difference …
Decompression alone or decompression with fusion for lumbar spinal stenosis: five-year clinical results from a randomized clinical trial.
Karlsson T, Försth P, Öhagen P, Michaëlsson K, Sandén B. Karlsson T, et al. Bone Joint J. 2024 Jul 1;106-B(7):705-712. doi: 10.1302/0301-620X.106B7.BJJ-2023-1160.R2. Bone Joint J. 2024. PMID: 38945544 Clinical Trial.
Secondary outcomes were the EuroQol five-dimension questionnaire (EQ-5D), visual analogue scales for back and leg pain, and patient-reported satisfaction, decreased pain, and increased walking distance. ...After five years, ODI was similar irrespective of treatment, with a …
Secondary outcomes were the EuroQol five-dimension questionnaire (EQ-5D), visual analogue scales for back and leg pain, and patient-r …
Five-year follow-up after minimally invasive transforaminal lumbar interbody fusion versus decompression alone for grade 1 spondylolisthesis: are there any differences in outcomes?
Chan AK, Ambati VS, Upadhyayula P, Chou D, Bydon M, Bisson EF, Glassman SD, Foley KT, Shaffrey CI, Potts EA, Yen CP, Coric D, Knightly JJ, Park P, Wang MY, Fu KM, Slotkin JR, Asher AL, Virk MS, Haid RW, Mummaneni PV. Chan AK, et al. J Neurosurg Spine. 2025 Aug 29;43(5):547-556. doi: 10.3171/2025.5.SPINE25324. Print 2025 Nov 1. J Neurosurg Spine. 2025. PMID: 40882242
Uni- and multivariable analyses compared outcomes including the Oswestry Disability Index (ODI), numeric rating scale (NRS) for back pain (NRS-BP), NRS for leg pain (NRS-LP), EuroQol-5D (EQ-5D), North American Spine Society (NASS) satisfaction score, and cumulative …
Uni- and multivariable analyses compared outcomes including the Oswestry Disability Index (ODI), numeric rating scale (NRS) for back pain (N …
Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review.
Poudel N, Fahim SM, Qian J, Garza K, Chaiyakunapruk N, Ngorsuraches S. Poudel N, et al. J Med Econ. 2022 Jan-Dec;25(1):571-582. doi: 10.1080/13696998.2022.2066441. J Med Econ. 2022. PMID: 35416095 Free article.
OBJECTIVES: (1) To descriptively compare the selected elements of valuation methods for EQ-5D-5L value set studies, (2) to compare the characteristics of the value sets, and (3) to examine the associations between the selected elements of valuation methods and the EQ-5D …
OBJECTIVES: (1) To descriptively compare the selected elements of valuation methods for EQ-5D-5L value set studies, (2) to compare th …
Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome.
Malin SK, Heiston EM, Battillo DJ, Ragland TJ, Gow AJ, Shapses SA, Shah AM, Patrie JT, Barrett EJ. Malin SK, et al. J Clin Endocrinol Metab. 2026 Mar 17;111(4):e1124-e1135. doi: 10.1210/clinem/dgaf551. J Clin Endocrinol Metab. 2026. PMID: 41160096 Clinical Trial.
METHODS: In a double-blind, placebo-controlled trial, participants were randomly assigned to low-intensity exercise plus placebo ( 55% VO2max 5d/wk, LoEx + PL, n = 22) or metformin (2000 mg/d, LoEx + Met, n = 21) and high-intensity exercise plus placebo ( 85% VO2max …
METHODS: In a double-blind, placebo-controlled trial, participants were randomly assigned to low-intensity exercise plus placebo ( 55% VO2ma …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis.
Yang Z, Li S, Wang X, Chen G. Yang Z, et al. J Dermatolog Treat. 2022 Mar;33(2):1029-1036. doi: 10.1080/09546634.2020.1800571. Epub 2020 Aug 9. J Dermatolog Treat. 2022. PMID: 32716651 Free article.
For meta-analysis, we identified 70 utility scores from 59 studies: 22 for plaque psoriasis, 26 for psoriasis as a general condition, and 22 for psoriatic arthritis. ...Heterogeneity exists among different EQ-5D utility values found in the literature....
For meta-analysis, we identified 70 utility scores from 59 studies: 22 for plaque psoriasis, 26 for psoriasis as a general condition, …
Comparison of the three-level and the five-level versions of the EQ-5D.
Christiansen ASJ, Møller MLS, Kronborg C, Haugan KJ, Køber L, Højberg S, Brandes A, Graff C, Diederichsen SZ, Nielsen JB, Krieger D, Holst AG, Svendsen JH. Christiansen ASJ, et al. Eur J Health Econ. 2021 Jun;22(4):621-628. doi: 10.1007/s10198-021-01279-z. Epub 2021 Mar 18. Eur J Health Econ. 2021. PMID: 33733344
A total of 1002 persons diagnosed with hypertension, diabetes, heart failure, and/or previous stroke completed both the EQ-5D-3L and the EQ-5D-5L questionnaires. The overall ceiling effect decreased from 46% with the EQ-5D-3L to 30% with the EQ-5D-5L a …
A total of 1002 persons diagnosed with hypertension, diabetes, heart failure, and/or previous stroke completed both the EQ-5D-3L and …
1,076 results